Skip to primary content
Skip to secondary content

gutsandgrowth

Pediatric Gastroenterology

gutsandgrowth

Main menu

  • Home
  • About Jay Hochman -Pediatric Gastroenterology Blog

Tag Archives: fattly liver disease

Fatty Liver Feast (of Articles): NAFLD 2020

Posted on July 12, 2020 by gutsandgrowth

An entire issue of Gastroenterology delved into the topics of “NAFLD 2020.”

This special May 2020 issue provides a comprehensive update on Nonalcoholic Fatty Liver Disease.

Here are a few links to some of the articles:

  • TG Cotter, M Rinella. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
  • M Eslam, AJ Sanyal, J George. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease This article similar to a previous article (Improving Fatty Liver Nomenclature) suggests changing the name for NAFLD to MAFLD.
  • D Goldner, JE Lavine. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges

Related blog posts:

  • Pediatric NAFLD: You Don’t Have to be Obese/Overweight to have Fatty Liver Disease (but it helps)
  • Should Teenagers with Severe NAFLD Undergo Bariatric Surgery?
  • Concise Review: Fatty Liver in Pediatrics
  • Reaching Consensus on Bariatric Intervention in Children …
  • Is a Three Year-Old Too Young for Bariatric Surgery …
  • Should We Be Excited About a New Medication (Liraglutide …
  • Overlooking Obesity in Hospitalized Children | gutsandgrowth
  • Treating diabetes with surgery | gutsandgrowth

Posted in Hepatology, Pediatric Gastroenterology Liver Disease | Tagged fattly liver disease, MAFLD, nonalcoholic fatty liver disease

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Top Posts & Pages

  • 75% of U.S. Adults Have Obesity When Using New Definition With Anthropometrics
  • In the News: FDA Approves 2nd Oral GLP-1, Another Vaccine Reduces Risk of Dementia, and Costs of Vaccine-Preventable Diseases
  • Position Paper: Expediting Drug Approval for Pediatric IBD
  • Choosing Advanced Therapy for Crohn's Disease Based on Disease Location
  • Reduced Dosing of GLP-1 RAs May Work for Maintenance Treatment of Obesity
  • Shingles Vaccine Linked to Lower Dementia Risk
  • Flu Shots & Other Vaccines Linked to Lower Rates of Dementia
  • Oral GLP-1 Receptor Agonist for Obesity: Orforglipron
  • Comprehensive ACG Clinical Guidelines for Ulcerative Coliits (2025)
  • The Rise of Oral Obesity Therapies: Semaglutide and Orforglipron

Log-In

  • Create account
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com

Recent Posts

  • Choosing Advanced Therapy for Crohn’s Disease Based on Disease Location
  • In the News: FDA Approves 2nd Oral GLP-1, Another Vaccine Reduces Risk of Dementia, and Costs of Vaccine-Preventable Diseases
  • Position Paper: Expediting Drug Approval for Pediatric IBD
  • Upadacitinib for Pediatric Ulcerative Colitis
  • Food for Thought: Studies of Food Intake and IBS and DGBI
  • Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists For Inflammatory Bowel Disease Patients
  • “Real-World” Experience: High Dose Upadacitinib Recaptures IBD Response
Blog at WordPress.com.
  • Subscribe Subscribed
    • gutsandgrowth
    • Join 945 other subscribers
    • Already have a WordPress.com account? Log in now.
    • gutsandgrowth
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...